Immune Responses With Reduxium
Clinical trial NCT04525456 · COMPLETED
Trial details
- NCT number
- NCT04525456
- Sponsor
- Ogevity Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2020-12-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.